Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Mechanisms of action and clinical research progress of photobiomodulation

PBM offers unique advantages, including safety, minimal tissue damage, and low cost.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review summarizes the molecular mechanisms and clinical research progress of photobiomodulation, which uses low-intensity visible or near-infrared light (600-1100 nm). The authors report that PBM shows potential in wound healing, neurodegenerative disease, and adjunctive cancer therapy, with effects that depend on wavelength and dose. The authors note that parameter variation creates uncertainty in therapeutic efficacy.

Who or what was studied
unclear
Wavelengths
600, 1100 nm
Limits stated in the abstract
The abstract acknowledges uncertainty in therapeutic efficacy caused by parameter variations and a lack of systematic review of multidimensional mechanisms.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Photobiomodulation (PBM) involves the application of low-intensity visible or near-infrared light (600-1100 nm) to tissues. PBM demonstrates considerable potential in chronic wound healing, neurodegenerative disease intervention, and adjunctive cancer therapy. The core mechanism of PBM relies on photon absorption at specific wavelengths by mitochondrial cytochrome c oxidase. By activating the mitochondrial electron transport chain, enhancing ATP synthesis, and regulating reactive oxygen species signaling, PBM mediates multiple downstream signaling pathways, including PI3K/Akt, MAPK, and NF-κB, thereby exhibiting significant wavelength- and dose-dependent bidirectional regulatory characteristics. Currently, domestic and international research primarily focuses on single signaling pathways or therapeutic effects for specific diseases, while lacking a systematic review of their multidimensional regulatory mechanisms and multisystem biological effects. This hinders the standardization of treatment parameters and optimization of clinical protocols. Accordingly, this review systematically summarizes the molecular mechanisms and research progress of PBM across five major areas: tissue repair and regeneration, anti-inflammatory and immunomodulatory effects, regulation of glucose and lipid metabolism, tumor intervention, and neuroprotection and analgesia. We identify current research bottlenecks and recognize the uncertainty in therapeutic efficacy caused by parameter variations, along with outlining pathways for its precise and personalized clinical translation. PBM offers unique advantages, including safety, minimal tissue damage, and low cost. These features make it a promising, novel adjunctive therapeutic modality and provide a systematic theoretical basis for developing non-invasive adjunctive phototherapy regimens for various refractory diseases.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
600-1100 nm

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Reactive oxygen species, Adenosine triphosphate, Cytochrome c oxidase, Systematic review, Near-infrared, Wound healing, Phototherapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies